BDBM2544 US8507510, 1.23::US8507510, 1.41

SMILES COc1cc(Nc2ncc(Br)c(N[C@H](C)C(C)(C)O)n2)ccc1S(C)(=N)=O

InChI Key InChIKey=VEMUNZLIOXAWMA-UHFFFAOYSA-N

Data  6 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 6 hits for monomerid = 2544   

TargetCyclin-dependent kinase 2(Human)
Bayer Intellectual Property

US Patent
LigandPNGBDBM2544(US8507510, 1.23 | US8507510, 1.41)
Affinity DataIC50: 2nMAssay Description:Kinase assay using either CDK1, CDK2 or VEGFR-2.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2013
Entry Details
Go to US Patent

TargetCyclin-dependent kinase 1(Human)
Bayer Intellectual Property

US Patent
LigandPNGBDBM2544(US8507510, 1.23 | US8507510, 1.41)
Affinity DataIC50: 2nMAssay Description:Kinase assay using either CDK1, CDK2 or VEGFR-2.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2013
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Bayer Intellectual Property

US Patent
LigandPNGBDBM2544(US8507510, 1.23 | US8507510, 1.41)
Affinity DataIC50: 76nMAssay Description:Kinase assay using either CDK1, CDK2 or VEGFR-2.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2013
Entry Details
Go to US Patent

TargetCyclin-dependent kinase 2(Human)
Bayer Intellectual Property

US Patent
LigandPNGBDBM2544(US8507510, 1.23 | US8507510, 1.41)
Affinity DataIC50: 6nMAssay Description:Kinase assay using either CDK1, CDK2 or VEGFR-2.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2013
Entry Details
Go to US Patent

TargetCyclin-dependent kinase 1(Human)
Bayer Intellectual Property

US Patent
LigandPNGBDBM2544(US8507510, 1.23 | US8507510, 1.41)
Affinity DataIC50: 8nMAssay Description:Kinase assay using either CDK1, CDK2 or VEGFR-2.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2013
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Bayer Intellectual Property

US Patent
LigandPNGBDBM2544(US8507510, 1.23 | US8507510, 1.41)
Affinity DataIC50: 75nMAssay Description:Kinase assay using either CDK1, CDK2 or VEGFR-2.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2013
Entry Details
Go to US Patent